Antidepressants and cancer: cause for concern?

Response to "Antidepressants and cancer: cause for concern?". J Clin Psychopharmacol (1993) 1.95

The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer (2002) 1.04

A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98

Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. J Bacteriol (1967) 5.67

Lincomycin: activity against anaerobes and effect on normal human fecal flora. Antimicrob Agents Chemother (Bethesda) (1965) 3.29

Metabolism of reduced methylated sulfur compounds in anaerobic sediments and by a pure culture of an estuarine methanogen. Appl Environ Microbiol (1986) 3.25

Selenate reduction to elemental selenium by anaerobic bacteria in sediments and culture: biogeochemical significance of a novel, sulfate-independent respiration. Appl Environ Microbiol (1989) 2.74

Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J Bacteriol (1967) 2.21

Isolation, Growth, and Metabolism of an Obligately Anaerobic, Selenate-Respiring Bacterium, Strain SES-3. Appl Environ Microbiol (1994) 2.13

Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect (2009) 2.04

Arsenic(III) fuels anoxygenic photosynthesis in hot spring biofilms from Mono Lake, California. Science (2008) 1.98

Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest (1982) 1.76

Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates. Appl Environ Microbiol (1996) 1.72

Ataxia and slurred speech after artesunate treatment for falciparum malaria. N Engl J Med (1997) 1.72

White paper on herbal products. American College of Clinical Pharmacy. Pharmacotherapy (2000) 1.58

Degradation of methyl bromide by methanotrophic bacteria in cell suspensions and soils. Appl Environ Microbiol (1994) 1.54

Bacterial oxidation of methyl bromide in fumigated agricultural soils. Appl Environ Microbiol (1997) 1.53

Dissimilatory arsenate and sulfate reduction in sediments of two hypersaline, arsenic-rich soda lakes: Mono and Searles Lakes, California. Appl Environ Microbiol (2006) 1.52

Patients with methicillin-resistant Staphylococcus aureus infection: twenty-first century lepers. J Hosp Infect (2010) 1.48

Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Mov Disord (1989) 1.44

Possible interaction between fluoxetine and pimozide causing sinus bradycardia. Can J Psychiatry (1993) 1.41

What is the relevance of antiretroviral therapy that does not include protease inhibitors? Clin Infect Dis (1998) 1.39

Toward a greater understanding of the parents of the mentally retarded child. J Pediatr (1968) 1.39

Estimating the cost of nosocomial candidemia in the united states. Clin Infect Dis (2001) 1.38

The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clin Microbiol Infect (2012) 1.34

In situ bacterial selenate reduction in the agricultural drainage systems of western Nevada. Appl Environ Microbiol (1991) 1.23

Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review. Epidemiol Infect (2009) 1.19

T-lymphocyte subsets in smoking and lung cancer: Analysis of monoclonal antibodies and flow cytometry. Am Rev Respir Dis (1982) 1.17

Observations on the distribution and ecology of Clostridium botulinum type E in Alaska. Can J Microbiol (1975) 1.16

Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Clin Infect Dis (2001) 1.13

Advice of manufacturers about effects of temperature on biologicals. Am J Hosp Pharm (1985) 1.09

Anaerobic bacteria as cause of the blind loop syndrome. A case report with observations on response to antibacterial agents. Gastroenterology (1968) 0.98

Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading, and co-active on drug release. Pharm Dev Technol (1997) 0.96

Non-suppurative cellulitis: risk factors and its association with Staphylococcus aureus colonization in an area of endemic community-associated methicillin-resistant S. aureus infections. Epidemiol Infect (2010) 0.94

Possible origin of Clostridium botulinum contamination of Eskimo foods in northwestern Alaska. Appl Microbiol (1972) 0.94

Experimental Brucella suis type 4 infections in domestic and wild Alaskan carnivores. J Wildl Dis (1981) 0.93

Asbestos exposure correlates with alterations in circulating T cell subsets. Clin Exp Immunol (1983) 0.93

Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone. Brain Res Bull (1992) 0.92

Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons. Transpl Infect Dis (2012) 0.91

Degradation of methyl bromide in anaerobic sediments. Environ Sci Technol (1994) 0.91

Further studies on tularemia in Alaska: virulence and biochemical characteristics of indigenous strains. Can J Microbiol (1974) 0.90

Methylmercury oxidative degradation potentials in contaminated and pristine sediments of the carson river, nevada. Appl Environ Microbiol (1995) 0.89

Further studies on tularemia in Alaska: human tularemia. Can J Microbiol (1974) 0.88

Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J Pharmacol Exp Ther (1994) 0.88

Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration. Br J Pharmacol (1991) 0.88

Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development. Infection (2007) 0.86

T-lymphocyte subsets in peripheral blood and lung lavage in idiopathic pulmonary fibrosis and sarcoidosis: analysis by monoclonal antibodies and flow cytometry. Clin Immunol Immunopathol (1982) 0.85

Experimental infections by Brucella suis type 4 in Alaskan rodents. J Wildl Dis (1980) 0.85

Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding. Eur J Pharmacol (1989) 0.84

Kinetic and dynamic components of increased benzodiazepine sensitivity in aging animals. J Pharmacol Exp Ther (1990) 0.83

[The effect of the vertebral nerve on circulation in the inner ear (cochlea)]. Biull Eksp Biol Med (1973) 0.83

Fluoxetine-induced SIADH: a geriatric occurrence? J Fam Pract (1993) 0.83

Chronic morphine administration augments benzodiazepine binding and GABAA receptor function. Psychopharmacology (Berl) (1990) 0.82

Prenatal cocaine exposure: decreased sensitization to cocaine and decreased striatal dopamine transporter binding in offspring. Neuropharmacology (1993) 0.82

Pregnenolone sulfate potentiation of NMDA-mediated increases in intracellular calcium in cultured chick cortical neurons. Brain Res (1995) 0.81

Isolation and characterization of the promoter of the human GABAA receptor alpha 1 subunit gene. J Neurochem (1994) 0.81

Continuous flow stable isotope methods for study of delta(13)C fractionation during halomethane production and degradation. Rapid Commun Mass Spectrom (2001) 0.81

Rapid increase in brain benzodiazepine receptor binding following defeat stress in mice. Brain Res (1987) 0.81

Prenatal exposure to benzodiazepine--I. Prenatal exposure to lorazepam in mice alters open-field activity and GABAA receptor function. Neuropharmacology (1991) 0.81

A comparison of clinical outcomes between healthcare-associated infections due to community-associated methicillin-resistant Staphylococcus aureus strains and healthcare-associated methicillin-resistant S. aureus strains. Epidemiol Infect (2012) 0.80

The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation. Pharmacology (1997) 0.80

Benzodiazepine discontinuation syndromes. J Psychiatr Res (1990) 0.80

Polyamine neurotoxicity is antagonized by dizocilpine in cultured chick cortical neurons. Neurosci Lett (1993) 0.80

Clonazepam pharmacokinetics, brain uptake, and receptor interactions. J Clin Psychiatry (1987) 0.80

Helping parents cope with the retarded child. Northwest Med (1969) 0.80

Peripheral type benzodiazepine receptor and airway smooth muscle relaxation. J Pharmacol Exp Ther (1988) 0.80

Prenatal cocaine exposure: increased striatal dopamine transporter binding in offspring at 3 and 6 months of age. Brain Res Bull (1994) 0.79

Chronic administration of benzodiazepines--V. Rapid onset of behavioral and neurochemical alterations after discontinuation of alprazolam. Neuropharmacology (1990) 0.79

Nalidixic acid: clinical and laboratory studies. Antimicrob Agents Chemother (Bethesda) (1966) 0.79

Benzodiazepine receptor binding: influence of physiologic and pharmacologic factors. Biopharm Drug Dispos (1987) 0.79

Electroconvulsive shock alters GABAA receptor subunit mRNAs: use of quantitative PCR methodology. Brain Res Bull (1993) 0.79

Effects of chronic drug use: defining our terms. J Clin Psychopharmacol (1988) 0.78

Mental age and I.Q. of predominantly vegetarian children. J Am Diet Assoc (1980) 0.78

Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function. Br J Pharmacol (1990) 0.78

Persistent elevation in GABAA receptor subunit mRNAs following social stress. Brain Res Bull (1991) 0.78

Low-dose alprazolam augments motor activity in mice. Pharmacol Biochem Behav (1988) 0.78

Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration. Psychopharmacology (Berl) (1991) 0.78

Trazodone kinetics: effect of age, gender, and obesity. Clin Pharmacol Ther (1987) 0.78

High resolution neutron-induced autoradiography of bone containing 239 Pu. Health Phys (1972) 0.78

Metabolism of naturally occurring and 14-C-labeled triglycerides in the sheep. J Anim Sci (1969) 0.77

GABAA receptor mRNAs are increased after electroconvulsive shock. Psychopharmacol Bull (1991) 0.77

Increased GABAA-dependent chloride uptake in mice selectively bred for low aggressive behavior. Psychopharmacology (Berl) (1992) 0.77

Glutamate, kainate and quisqualate enhance GABA-dependent chloride uptake in cortex. Brain Res Bull (1990) 0.77

Neurochemical and pharmacokinetic correlates of the clinical action of benzodiazepine hypnotic drugs. Am J Med (1990) 0.77

Chronic benzodiazepine administration. VIII. Receptor upregulation produced by chronic exposure to the inverse agonist FG-7142. J Pharmacol Exp Ther (1991) 0.76

Characterization of Ca2(+)-mobilizing excitatory amino acid receptors in cultured chick cortical cells. Eur J Pharmacol (1990) 0.76

Effect of exogenous carnitine on carnitine homeostasis in the rat. Biochim Biophys Acta (1991) 0.76

Lorazepam discontinuation promotes 'inverse agonist' effects of benzodiazepines. Br J Pharmacol (1989) 0.76

Cocaine augments peripheral benzodiazepine binding in humans. J Clin Psychiatry (1990) 0.75

Chronic low-dose alprazolam augments gamma-aminobutyric acid(A) receptor function. J Clin Psychopharmacol (1992) 0.75

Physician assistants and nurse practitioners. Ann Intern Med (1995) 0.75

Acute effects of benzodiazepines on operant behavior and in vivo receptor binding in mice. Pharmacol Biochem Behav (1994) 0.75

[The effect of foridon on the cerebral circulation in non-narcotized animals]. Eksp Klin Farmakol (1994) 0.75

Polyamine potentiation and inhibition of NMDA-mediated increases of intracellular free Ca2+ in cultured chick cortical neurons. Eur J Pharmacol (1994) 0.75

Nonsporulating anaerobic bacteria in osteomyelitis. Antimicrob Agents Chemother (Bethesda) (1967) 0.75

[Experimental and clinical research on the effect of senzit on the cerebral blood flow and hemostatic function in cerebral ischemia]. Farmakol Toksikol (1986) 0.75

Pre-natal benzodiazepine exposure. III. Lorazepam exposure is associated with a shift toward inverse agonist efficacy. J Psychopharmacol (1993) 0.75

Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam. Psychopharmacology (Berl) (1993) 0.75

Determination of zopiclone in plasma by liquid chromatography with application to steady-state monitoring. J Chromatogr (1986) 0.75

Pharmacy cognitive services and mail order pharmacies. Nebr Med J (1994) 0.75

Use of sodium bicarbonate vials or syringes to buffer cardioplegic solutions. Am J Hosp Pharm (1986) 0.75

Update on the new triphasic oral contraceptives. Clin Pharm (1985) 0.75